{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:08:44Z","timestamp":1790968124443,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.humpath.2022.11.002","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T23:32:13Z","timestamp":1668036733000},"page":"87-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Different clinico-pathological and prognostic features of vulvar, vaginal, and cervical melanomas"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2355-0887","authenticated-orcid":false,"given":"Yan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3440-9077","authenticated-orcid":false,"given":"Zhongwu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.11.002_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/CMR.0b013e32833684e8","article-title":"Population-based incidence of vulvar and vaginal melanoma in various races and ethnic groups with comparisons to other site-specific melanomas","volume":"20","author":"Hu","year":"2010","journal-title":"Melanoma Res"},{"key":"10.1016\/j.humpath.2022.11.002_bib2","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1245\/s10434-018-6503-9","article-title":"Multifactorial analysis of prognostic factors and survival rates among 706 mucosal melanoma patients","volume":"25","author":"Cui","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2022.11.002_bib3","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.ydbio.2018.03.024","article-title":"The issue of the multipotency of the neural crest cells","volume":"444","author":"Dupin","year":"2018","journal-title":"Dev Biol"},{"key":"10.1016\/j.humpath.2022.11.002_bib4","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/1097-0142(196407)17:7<912::AID-CNCR2820170711>3.0.CO;2-F","article-title":"Melanoblasts in vaginal mucosa. Origin for primary malignant melanoma","volume":"17","author":"Nigogosyan","year":"1964","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2022.11.002_bib5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/PGP.0000000000000636","article-title":"Mutational profile in vulvar, vaginal, and urethral melanomas: review of 37 cases with focus on primary tumor site","volume":"39","author":"Zarei","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2022.11.002_bib6","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1111\/jdv.16306","article-title":"Prognostic factors in 161 patients with mucosal melanoma: a study of German Central Malignant Melanoma Registry","volume":"34","author":"Sarac","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.humpath.2022.11.002_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.critrevonc.2011.03.008","article-title":"A literature overview of primary cervical malignant melanoma: an exceedingly rare cancer","volume":"81","author":"Pusceddu","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.humpath.2022.11.002_bib8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ygyno.2018.04.562","article-title":"Melanoma of the lower genital tract: prognostic factors and treatment modalities","volume":"150","author":"Gadducci","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2022.11.002_bib9","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/CMR.0000000000000469","article-title":"Primary malignant melanoma of the cervix: 14 cases and literature overview","volume":"28","author":"Sun","year":"2018","journal-title":"Melanoma Res"},{"key":"10.1016\/j.humpath.2022.11.002_bib10","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/annonc\/mdx079","article-title":"Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial","volume":"28","author":"Guo","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2022.11.002_bib11","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/cncr.30663","article-title":"A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: a trial of the ECOG-ACRIN Cancer Research Group (E2607)","volume":"123","author":"Kalinsky","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2022.11.002_bib12","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.3802\/jgo.2019.30.e94","article-title":"Investigating the role of immunotherapy in advanced\/recurrent female genital tract melanoma: a preliminary experience","volume":"30","author":"Indini","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.humpath.2022.11.002_bib13","first-page":"190","article-title":"Primary melanoma of the vagina: a clinicopathologic analysis","volume":"74","author":"Reid","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.humpath.2022.11.002_bib14","article-title":"Surgical outcomes of vaginal or cervical melanoma","volume":"8","author":"Tian","year":"2021","journal-title":"Frontiers in surgery"},{"key":"10.1016\/j.humpath.2022.11.002_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2021.102091","article-title":"Vulvar and vaginal melanomas: a retrospective study spanning 19 years from a tertiary center","volume":"50","author":"Joste","year":"2021","journal-title":"Journal of gynecology obstetrics and human reproduction"},{"key":"10.1016\/j.humpath.2022.11.002_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejca.2011.06.056","article-title":"Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort","volume":"48","author":"Si","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2022.11.002_bib17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.AOG.0000271209.67461.91","article-title":"Vulvar melanoma: a multivariable analysis of 644 patients","volume":"110","author":"Sugiyama","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.humpath.2022.11.002_bib18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4274\/tjod.galenos.2020.44789","article-title":"Female genital tract melanoma: analysis from a regional cancer institute","volume":"17","author":"Pandey","year":"2020","journal-title":"Turk J Obstet Gynecol"},{"key":"10.1016\/j.humpath.2022.11.002_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejca.2017.05.014","article-title":"Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma","volume":"81","author":"Heppt","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2022.11.002_bib20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/exd.13472","article-title":"BRAF mutations might be more common than supposed in vulvar melanomas","volume":"27","author":"Wylomanski","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.humpath.2022.11.002_bib21","first-page":"4017","article-title":"Primary malignant melanomas of the female lower genital tract: clinicopathological characteristics and management","volume":"10","author":"Wang","year":"2020","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.humpath.2022.11.002_bib22","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/cncr.30473","article-title":"Vulvar and vaginal melanoma: a unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma","volume":"123","author":"Hou","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2022.11.002_bib23","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/modpathol.2013.211","article-title":"Comparison of molecular abnormalities in vulvar and vaginal melanomas","volume":"27","author":"Aulmann","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.11.002_bib24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1186\/s12885-021-08427-x","article-title":"Recurrent KRAS, KIT and SF3B1 mutations in melanoma of the female genital tract","volume":"21","author":"Cai","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.humpath.2022.11.002_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/303791","article-title":"Low mutational burden of eight genes involved in the MAPK\/ERK, PI3K\/AKT, and GNAQ\/11 pathways in female genital tract primary melanomas","volume":"2015","author":"Pappa","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.humpath.2022.11.002_bib26","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/jdv.14353","article-title":"Mucosal melanoma: clinical, histological and c-kit gene mutational profile of 86 French cases","volume":"31","author":"Cinotti","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.humpath.2022.11.002_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40257-018-0414-1","article-title":"KIT as an oncogenic driver in melanoma: an update on clinical development","volume":"20","author":"Meng","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.humpath.2022.11.002_bib28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(13)70024-X","article-title":"MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study","volume":"14","author":"Ascierto","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2022.11.002_bib29","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/LGT.0000000000000591","article-title":"Female genital tract melanoma: 10 Years of experience at a single tertiary center","volume":"25","author":"Lewin","year":"2021","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.humpath.2022.11.002_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2015.11.009","article-title":"Primary genitourinary melanoma: epidemiology and disease-specific survival in a large population-based cohort","volume":"34","author":"Sanchez","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.humpath.2022.11.002_bib31","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/00000478-200211000-00007","article-title":"Vaginal melanoma: a clinicopathologic and immunohistochemical study of 26 cases","volume":"26","author":"Gupta","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.11.002_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.humpath.2018.05.004","article-title":"Prognostic factors in primary anorectal melanoma: a clinicopathological study of 60 cases in China","volume":"79","author":"Ren","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.11.002_bib33","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1200\/JCO.2014.58.1967","article-title":"Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers","volume":"33","author":"Denkert","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2022.11.002_bib34","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1158\/1078-0432.CCR-21-1060","article-title":"Genomic correlates of outcome in tumor-infiltrating lymphocyte therapy for metastatic melanoma","volume":"28","author":"Creasy","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2022.11.002_bib35","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/jamadermatol.2017.2444","article-title":"Association of incident amelanotic melanoma with phenotypic characteristics, MC1R status, and prior amelanotic melanoma","volume":"153","author":"Vernali","year":"2017","journal-title":"JAMA dermatology"},{"key":"10.1016\/j.humpath.2022.11.002_bib36","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3892\/ijmm.2014.1659","article-title":"A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker","volume":"33","author":"Heinzelmann-Schwarz","year":"2014","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.humpath.2022.11.002_bib37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0039-6060(98)70073-X","article-title":"Mucosal melanoma of the female genitalia: a clinicopathologic study of forty-three cases at Duke University Medical Center","volume":"124","author":"DeMatos","year":"1998","journal-title":"Surgery"},{"key":"10.1016\/j.humpath.2022.11.002_bib38","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jaad.2011.11.921","article-title":"Clinicopathologic study of 85 cases of melanoma of the female genitalia","volume":"67","author":"Tcheung","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.humpath.2022.11.002_bib39","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1158\/1078-0432.CCR-16-2126","article-title":"Tumor thickness and mitotic rate robustly predict melanoma-specific survival in patients with primary vulvar melanoma: a retrospective review of 100 cases","volume":"23","author":"Nagarajan","year":"2017","journal-title":"Clin Cancer Res"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722002593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817722002593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:40:46Z","timestamp":1758645646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817722002593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":39,"alternative-id":["S0046817722002593"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.11.002","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different clinico-pathological and prognostic features of vulvar, vaginal, and cervical melanomas","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}